Petros Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Petros Pharmaceuticals Inc cash flow-to-debt ratio. Petros Pharmaceuticals Inc (PTPI) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2025, meaning its operating cash flow of $-1.49 Million could theoretically repay 0% of its total liabilities ($27.19 Million) in one year. Check Petros Pharmaceuticals Inc (PTPI) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Petros Pharmaceuticals Inc (2018–2024)
Cash flow-to-debt ratio of Petros Pharmaceuticals Inc from 2018 to 2024. Historical debt coverage capacity for Petros Pharmaceuticals Inc across 7 annual periods. Check Petros Pharmaceuticals Inc (PTPI) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Petros Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2018–2024)
Petros Pharmaceuticals Inc cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for Petros Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Petros Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.14x | $-2.60 Million | $18.10 Million | ▲ +59.8% |
| 2023 | -0.36x | $-7.63 Million | $21.32 Million | ▲ +56.1% |
| 2022 | -0.81x | $-12.80 Million | $15.72 Million | ▼ -118.6% |
| 2021 | -0.37x | $-11.86 Million | $31.85 Million | ▼ -27.5% |
| 2020 | -0.29x | $-15.31 Million | $52.38 Million | ▼ -680.9% |
| 2019 | 0.05x | $2.53 Million | $50.35 Million | ▼ -57.0% |
| 2018 | 0.12x | $8.02 Million | $68.57 Million | — |